Evaluation and treatment of hypertriglyceridemia: An endocrine society clinical practice guideline

Keyphrases

• Adult Treatment 14%
• Cardiovascular Risk 14%
• Clinical Practice Guidelines 100%
• Committee Member 14%
• Conference Calls 14%
• Consensus Process 14%
• Corporate Finance 14%
• Dietary Modification 14%
• Drug Therapy 14%
• Dyslipidemia and Cardiovascular Disease 14%
• Endocrine Society 100%
• Evidence Review 14%
• Family History 14%
• Fibrates 14%
• High-density Lipoprotein Cholesterol (HDL-C) 14%
• Hypertriglyceridemia 100%
• In-person Meetings 14%
• Initial Treatment 14%
• Lifestyle Therapy 14%
• Methodologists 14%
• National Cholesterol Education Program 14%
• Non-high-density Lipoprotein Cholesterol (non-HDL-C) 14%
• Pancreatitis 14%
• Remuneration 14%
• Secondary Causes 14%
• Severe Hypertriglyceridemia 28%
• Treatment Goals 14%
• Triglycerides 28%
• Very Severe 28%
• Written Comments 14%

Nursing and Health Professions

• Cardiovascular Disease 11%
• Cardiovascular Risk 11%
• Clinical Guideline 22%
• Drug Therapy 11%
• Dyslipidemia 11%
• Family History 11%
• Fibric Acid Derivative 11%
• High Density Lipoprotein Cholesterol Level 11%
• Hyperlipidemia 11%
• Hypertriglyceridemia 100%
• Methodologist 11%
• Pancreatitis 11%
• Practice Guideline 100%
• Systematic Review 11%
• Triacylglycerol 22%

Medicine and Dentistry

• Cardiovascular Disease 11%
• Cardiovascular Risk 11%
• Clinical Guideline 22%
• Drug Therapy 11%
• Dyslipidemia 11%
• Family History 11%
• High Density Lipoprotein Cholesterol 11%
• Hyperlipidemia 11%
• Hypertriglyceridemia 100%
• Methodologist 11%
• Pancreatitis 11%
• Systematic Review 11%
• Triacylglycerol 22%